Effect of COVID-19 on quality of life of persons aged >70 years with adult spinal deformity: A cross-sectional case-control study.

This observational, cross-sectional case-control study evaluates the impact of coronavirus disease 2019 (COVID-19) on health-related quality of life (HRQoL) in elderly persons who have undergone surgery for adult spinal deformity (ASD). On December 31, 2019, the Chinese authorities first reported severe acute respiratory syndrome coronavirus 2, and on March 11, 2020, it was declared a pandemic. The pandemic seems to have had a negative effect on elderly patients who underwent ASD, in terms of functional and psychological quality of life. We selected patients with ASD aged > 70 years who had undergone surgery between 2010 and 2015 and compared them with age- and sex-matched patients who did not have ASD. We recorded sociodemographic variables, type of surgery, levels of spinal fusion, HRQoL (Scoliosis Research Society-22, Short Form 12 Health Survey, EuroQol-5D [EQ-5], Geriatric Depression Scale [Yesavage] [GDS], Modified Frailty Index-11, and Barthel index), fear of visiting a health center, fear of leaving one's house, and adherence to preventive measures. The study population comprised 174 patients (mean [standard deviation] age, 77.3 [5.9] years; 86% women), of whom 87 had undergone surgery for ASD. The incidence of COVID-19 was higher in patients aged > 85 years (P = .041), urban areas (P = .047), and in patients in long-term care (P = .03). Similarly, no differences were observed for the ability to cope with the pandemic (P > .05). Patients who underwent surgery also had a higher risk of depression (GDS, 6.7 [P = .02]), a lower EQ-5 score (P = .001), a higher body mass index (P = .004), greater consumption of drugs (P < .001), especially opiates (P < .001). Patients who underwent surgery constitute a vulnerable population during the COVID-19 pandemic, with poorer quality of life and had a much higher risk of depression. They are also polymedicated and prefrail, adhere well to COVID-19 preventive measures, and do not seem to fear visiting health centers.

Prehabilitation in patients undergoing pancreaticoduodenectomy: a randomized controlled trial.

INTRODUCTION: prehabilitation has been proposed as an effective tool to prevent postoperative complications in patients undergoing major abdominal surgery. However, no studies have demonstrated its effectiveness in pancreatic surgical patients. The aim of this study was to assess the impact of prehabilitation on postoperative complications in patients undergoing a pancreaticoduodenectomy (PD). METHODS: this was a randomized controlled trial. Eligible candidates who accepted to participate were randomized to the control (standard care) or intervention (standard care + prehabilitation) group. All patients with pancreatic or periampullary tumors who were candidates for pancreaticoduodenectomy were included. Patients who received neoadjuvant treatment were excluded. Prehabilitation covered three actions: a) nutritional support; b) control of diabetes and exocrine pancreatic insufficiency; and c) physical and respiratory training. The main study outcome was the proportion of patients who suffered postoperative complications. Secondary outcomes included the occurrence of specific complications (pancreatic leak and delayed gastric emptying) and hospital stay. RESULTS: forty patients were included in the analysis. Twenty-two patients were randomized to the control arm and 18, to the intervention group. No statistically significant differences were observed in terms of overall and major complications between the prehabilitation and standard care groups. Pancreatic leak was not statistically different between the groups (11% vs 27%, p = 0.204). However, DGE was significantly lower in the prehabilitation group (5.6% vs 40.9% in the standard care group, p = 0.01). CONCLUSION: prehabilitation did not reduce postoperative complications following pancreaticoduodenectomy. However, a reduction in DGE was observed. Further studies are needed to validate the role and the timing of prehabilitation in high-risk patients.

Beneficios Nutricionales, Agroecológicos y Comerciales de las Legumbres / Nutritional, Agro-ecological and Commercial Benefits of Legumes

RESUMEN Las legumbres juegan un rol fundamental en la seguridad alimentaria y nutricional (SAN) de millones de personas en todo el mundo. Se estima que alrededor de 50 millones de agricultores familiares las producen, consumen y comercializan (a baja escala) de forma tradicional. La Asamblea General de las Naciones Unidas, en su 68° sesión en 2013, reconoció su importancia al declarar 2016 como el Año Internacional de las Legumbres (AIL2016). La Organización de las Naciones Unidas para la Alimentación y la Agricultura (FAO) fue designada para llevar a cabo las actividades de promoción del Año, en colaboración con gobiernos, organizaciones no gubernamentales, academia y otros actores relevantes interesados. El Año tiene como objetivo aumentar la conciencia pública sobre los beneficios nutricionales y para la salud que tienen las legumbres como parte de los sistemas alimentarios sostenibles dirigidos a mejorar la SAN; revalorizar su aporte de proteínas; promover su producción global; resaltar sus cualidades para mejorar la rotación de cultivos y adaptación al cambio climático; y dar respuesta a los retos para su comercialización.

ABSTRACT Legumes play a key role in food and nutritional security (FNS) for millions of people around the world, with an estimated 50 million family farmers producing, consuming and marketing (low-scale) legumes in a traditional way. At its 68th session in 2013, the General Assembly of the United Nations declared 2016 as the International Year of Legumes. The Food and Agriculture Organization of the United Nations was designated to facilitate the implementation of the legume year in collaboration with governments, non-governmental organizations, academia and other stakeholders. The purpose of the year of the legume was to increase public awareness of the nutritional and health benefits that legumes have, as part of a sustainable food systems, focused on improving FNS; revaluing legume-based proteins; promoting global production; highlighting its quality to encourage better crop rotation and adaptation to climate change; and responding to the markets challenges.

Preliminary results of a screening program for anal cancer and its precursors for HIV-infected men who have sex with men in Vigo-Spain.

BACKGROUND: Men who have sex with men (MSM) infected with human immunodeficiency virus (HIV) have the highest risk of developing anal cancer (AC). The objective of this study was to describe our screening implementation program in this population, and report the prevalence of human papillomavirus (HPV) anal infection, and cytological and histological findings in a Spanish medium-size community (Vigo, Spain). METHOD: Prospective cohort analysis of 240 HIV-infected MSM. Cellular anal sample and high risk HPV (HR-HPV)-tests were performed to study cytological changes and HPV genotyping. High resolution anoscopy (HRA) was performed in 209 patients. Results were analyzed with respect to epidemiological, clinical and analytical factors. RESULTS: Of 209 patients selected for HRA, the prevalence of HR-HPV anal infection, cytological and histological alterations was 85.6%, 47.5%, and 39.8%, respectively. Sensitivity and specificity for ≥ ASCUS (atypia of squamous cells of undetermined significance) cytology in relation to histological alterations were 61% and 85%, (OR: 8.7; IC 95%: 4.4-17.2), respectively. Observed concordance between high-grade squamous intraepithelial lesion (HSIL) cytology and HSIL anal intraepithelial neoplasia types 2 and 3 (AIN-2/3) histology was 64% (OR: 11.4; IC 95%: 3.6-36.7). One patient with HSIL cytology presented a prevalent anal squamous carcinoma. CONCLUSIONS: HRA was feasible with similar results to relevant groups. There was a high prevalence of anal HR-HPV infection, and cytological and histological alterations.

Presynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX).

Fast inhibitory glycinergic transmission occurs in spinal cord, brainstem, and retina to modulate the processing of motor and sensory information. After synaptic vesicle fusion, glycine is recovered back to the presynaptic terminal by the neuronal glycine transporter 2 (GlyT2) to maintain quantal glycine content in synaptic vesicles. The loss of presynaptic GlyT2 drastically impairs the refilling of glycinergic synaptic vesicles and severely disrupts neurotransmission. Indeed, mutations in the gene encoding GlyT2 are the main presynaptic cause of hyperekplexia in humans. Here, we show a novel endogenous regulatory mechanism that can modulate GlyT2 activity based on a compartmentalized interaction between GlyT2, neuronal plasma membrane Ca(2+)-ATPase (PMCA) isoforms 2 and 3, and Na(+)/Ca(2+)-exchanger 1 (NCX1). This GlyT2·PMCA2,3·NCX1 complex is found in lipid raft subdomains where GlyT2 has been previously found to be fully active. We show that endogenous PMCA and NCX activities are necessary for GlyT2 activity and that this modulation depends on lipid raft integrity. Besides, we propose a model in which GlyT2·PMCA2-3·NCX complex would help Na(+)/K(+)-ATPase in controlling local Na(+) increases derived from GlyT2 activity after neurotransmitter release.

Na+/K+-ATPase is a new interacting partner for the neuronal glycine transporter GlyT2 that downregulates its expression in vitro and in vivo.

The neuronal glycine transporter GlyT2 plays a fundamental role in the glycinergic neurotransmission by recycling the neurotransmitter to the presynaptic terminal. GlyT2 is the main supplier of glycine for vesicle refilling, a process that is absolutely necessary to preserve quantal glycine content in synaptic vesicles. Alterations in GlyT2 activity modify glycinergic neurotransmission and may underlie several neuromuscular disorders, such as hyperekplexia, myoclonus, dystonia, and epilepsy. Indeed, mutations in the gene encoding GlyT2 are the main presynaptic cause of hyperekplexia in humans and produce congenital muscular dystonia type 2 (CMD2) in Belgian Blue cattle. GlyT2 function is strictly coupled to the sodium electrochemical gradient actively generated by the Na+/K+-ATPase (NKA). GlyT2 cotransports 3Na+/Cl-/glycine generating large rises of Na+ inside the presynaptic terminal that must be efficiently reduced by the NKA to preserve Na+ homeostasis. In this work, we have used high-throughput mass spectrometry to identify proteins interacting with GlyT2 in the CNS. NKA was detected as a putative candidate and through reciprocal coimmunoprecipitations and immunocytochemistry analyses the association between GlyT2 and NKA was confirmed. NKA mainly interacts with the raft-associated active pool of GlyT2, and low and high levels of the specific NKA ligand ouabain modulate the endocytosis and total expression of GlyT2 in neurons. The ouabain-mediated downregulation of GlyT2 also occurs in vivo in two different systems: zebrafish embryos and adult rats, indicating that this NKA-mediated regulatory mechanism is evolutionarily conserved and may play a relevant role in the physiological control of inhibitory glycinergic neurotransmission.

Utilización de un nuevo tornillo expansivo en pacientes con mala calidad ósea: estudio multicéntrico / Utilização de um novo parafuso expansivo em pacientes com má qualidade óssea: estudo multicêntrico / Use of a new expansive screw in patients with poor bone quality: multicenter study

OBJETIVO: Observar el comportamiento del tornillo expansivo en pacientes con mala calidad ósea, su seguridad, técnica, manejo y complicaciones: porcentaje de aflojamiento, roturas, "pull-out" y pseudartrosis. MÉTODOS: Realizamos estudio prospectivo multicéntrico analizando factores de riesgo del paciente, VAS, tiempo quirúrgico, pérdida de sangre, emplazamiento de tornillos y complicaciones debidas al implante a la alta y a los 3, 12 y 24 meses. RESULTADOS: El 99% de los pacientes no tuvieron ninguna complicación permanente relacionada con el implante; sólo hubo un caso de radiculopatía no resuelta. En el 95% de los implantes, los tornillos se colocaron sin complicaciones; en el 5% aparecieron complicaciones relacionadas con la mala colocación o expansión del tornillo, resueltas en acto quirúrgico. Tiempo quirúrgico promedio por nivel, 56 min.; tiempo promedio por intervención, 2 horas 35 min. Sangramiento promedio por nivel intervenido, 211cc. Hemos tenido tres casos de "pull-out". El VAS evolucionó favorablemente de forma significativa, con reducciones promedio mayores a cuatro puntos. El estudio continuará hasta los cinco años, siendo estos los resultados preliminares. CONCLUSIONES: Este tipo de tornillos expansivos aportan un nuevo sistema de anclaje para pacientes con mala calidad ósea; son seguros y eficaces, ofrecen rapidez en su colocación, una menor exposición a los RXy, en caso de retirada del tornillo, dejan el camino libre para una nueva cirugía.

OBJETIVO: Observar o comportamento do parafuso expansivo em pacientes com má qualidade óssea, sua segurança, a técnica, conduta e complicações: porcentagem de afrouxamento, quebras, "pull-out" e pseudoartrose. MÉTODOS: Estudo prospectivo multicêntrico analisando fatores de risco do paciente, VAS, tempo cirúrgico, perda de sangue, localização dos parafusos e complicações devido ao implante na alta e aos 3, 12 e 24 meses. RESULTADOS: 99% dos pacientes não tiveram nenhuma complicação permanente relacionada com o implante; apenas um caso de radiculopatia não se resolveu. Em 95% dos implantes, os parafusos foram colocados sem complicações; em 5% houve complicações relacionadas com a má colocação ou expansão do parafuso, que foram resolvidas com cirurgia. Tempo médio de cirurgia por nível, 56 min.; tempo médio por intervenção, 2 horas e 35 min. Sangramento médio por nível que recebeu intervenção, 211 cc. Ocorreram três casos de "pull-out". A VAS evoluiu favoravelmente e de forma significante, con reduções médias maiores que quatro pontos. O estudo continuará até os cinco anos, sendo que estes são os resultados preliminares. CONCLUSÕES: Esse tipo de parafuso expansivo é um novo sistema de ancoragem para pacientes com má qualidade óssea; são seguros e eficazes, rápidos para colocar, proporcionam menos exposição aos RX e, em caso de retirada do parafuso, deixam o caminho livre para uma nova cirurgia.

OBJECTIVE: To observe the behavior of the expansive screw in patients with poor bone quality, its safety, the technique, conduct and complications: percentage of loosening, breaks, pull-outs and pseudoarthrosis. METHODS: Prospective multicenter study analyzing the patient’s risk factors, VAS, surgery time, blood loss, location of the screws and complications due to the implant at the time of discharge, and at 3, 12 and 24 months. RESULTS: 99% of the patients did not have any permanent complications related to the implant; there was only one case of unresolved radiculopathy. In 95% of the implants, the screws were placed without complications; in 5% percent of cases there were complications related to poor placement or expansion of the screw, which were resolved with the surgery. Mean intervention time per level: 56 minutes; average intervention time, 2 hours and 35 min. Average bleeding per level that received intervention, 211cc. There were three cases of "pull-out". VAS evolved favorably and significantly, with average reduction greater than four points. The study will continue until age five, these being the preliminary results. CONCLUSIONS: This type of expansive screw provides a new anchoring system for patients with poor bone quality; it is safe and effective, easy to insert, and provides less exposure to X-ray, and in case of removal of the screw, it leaves the way free for a new surgery.

A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.

Hyperekplexia or startle disease is characterized by an exaggerated startle response, evoked by tactile or auditory stimuli, producing hypertonia and apnea episodes. Although rare, this orphan disorder can have serious consequences, including sudden infant death. Dominant and recessive mutations in the human glycine receptor (GlyR) α1 gene (GLRA1) are the major cause of this disorder. However, recessive mutations in the presynaptic Na(+)/Cl(-)-dependent glycine transporter GlyT2 gene (SLC6A5) are rapidly emerging as a second major cause of startle disease. In this study, systematic DNA sequencing of SLC6A5 revealed a new dominant GlyT2 mutation: pY705C (c.2114A→G) in transmembrane domain 11, in eight individuals from Spain and the United Kingdom. Curiously, individuals harboring this mutation show significant variation in clinical presentation. In addition to classical hyperekplexia symptoms, some individuals had abnormal respiration, facial dysmorphism, delayed motor development, or intellectual disability. We functionally characterized this mutation using molecular modeling, electrophysiology, [(3)H]glycine transport, cell surface expression, and cysteine labeling assays. We found that the introduced cysteine interacts with the cysteine pair Cys-311-Cys-320 in the second external loop of GlyT2. This interaction impairs transporter maturation through the secretory pathway, reduces surface expression, and inhibits transport function. Additionally, Y705C presents altered H(+) and Zn(2+) dependence of glycine transport that may affect the function of glycinergic neurotransmission in vivo.

Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study).

BACKGROUND: There is a lack of prospective studies evaluating the natural history of colonic ischaemia (CI). We performed such a study to evaluate the clinical presentation, outcome, and mortality as well as clinical variables associated with poor prognosis. METHODS: An open, prospective, and multicentre study was conducted in 24 Spanish hospitals serving a population of 3.5 million people. The study included only patients who met criteria for definitive or probable CI. A website (www.colitisisquemica.org) provided logistical support. RESULTS: A total of 364 patients met criteria for inclusion. CI was suspected clinically in only 24.2% of cases. The distribution of clinical patterns was as follows: reversible colopathy (26.1%), transient colitis (43.7%), gangrenous colitis (9.9%), fulminant pancolitis (2.5%), and chronic segmental colitis (17.9%). A total of 47 patients (12.9%) had an unfavorable outcome as defined by mortality and/or the need for surgery. Multivariate analysis identified the following signs as independent risk factors for an unfavorable outcome: abdominal pain without rectal bleeding [odds ratio (OR) 3.9; 95% confidence interval (CI) = 1.6-9.3], non-bloody diarrhoea (OR 10; 95% CI = 3.7-27.4), and peritoneal signs (OR 7.3; 95% CI = 2.7-19.6). Unfavorable outcomes also were more frequent in isolated right colon ischaemia (IRCI) compared with non-IRCI (40.9 vs. 10.3%, respectively; p < 0.0001). The overall mortality rate was 7.7%. CONCLUSIONS: The clinical presentation of CI is very heterogeneous, perhaps explaining why clinical suspicion of this disease is so low. The presence of IRCI, and occurrence of peritoneal signs or onset of CI as severe abdominal pain without bleeding, should alert the physician to a potentially unfavorable course.

Morbilidad y mortalidad de los pacientes con insuficiencia respiratoria aguda en ventilación mecánica no invasiva en el Servicio de Cuidados Intensivos Generales de Adultos del Hospital Nacional Cayetano Heredia, 2007-2008 / Morbidity and mortality of patients with acute respiratory failure undergoing non-invasive mechanical ventilation in the Adult Intensive Care Unit in Hospital Nacional Cayetano Heredia, 2007-2008

Introducción: La vetilación mecánica no invasiva es una técnica de ventilación con una interfase ventilador - paciente a través de una máscara nasal o facial. Esto reduce la morbimortalidad asociada a la ventilación mecánica convencional asociadas a entubación endotraqueal y sedación relajación del paciente. Objetivos: Evaluar la morbilidad y mortalidad de los pacientes en ventilación mecánica no invasiva (VMNI), en el Servicio de Cuidados Intensivos Generales (SCIG) del Hospital Nacional Cayetano Heredia (HNCH), junio 2007 - mayo 2008. Material y método: La información se obtuvo de los archivos del SCIG de junio 2007 a mayo 2008. Se registró las variables fisiológicas al inicio y final de VMNI y se definió éxito y fracaso en VMNI. Los pacientes fueron manejados de forma individualizada según la guía de manejo de VMNI del SCIG del HNCH. Resultados: En un año de estudio se tuvo 30 pacientes en VMNI. La edad promedio de los pacientes fue 49,7 +/- 21; el 63,3% fueron mujeres, al inicio de la VMNI el score APACHE II fue 12,7 +/- 5,6, el SOFA: 4,3 +/- 2,2; el 66,7% presentó comorbilidades, de ellos 33,3% tuvo insuficiencia cardiaca; 23 (76,6%) pacientes tuvieron insuficiencia respiratoria tipo 1. De ellos, el edema agudo de pulmón y neumonía severa fueron las causas más frecuentes; una paciente (3,3%) insuficiencia respiratoria tipo 2; 6 pacientes (20,1%) insuficiencia respiratoria tipo 1 y 2. Se encontró diferencia significativa al final de la VMNI en los siguientes parámetros: disminución del trabajo respiratorio (p: 0,001); disminución de la frecuencia respiratoria (p: 0,004); disminución de la frecuencia cardiaca (p: 0,002); disminución de la presión arterial sistólica (p:0,016); reducción del requerimiento de Fi02 (p: 0,001) y aumento del Pa02/Fi02 (p: 0,001). El fracaso a la VMNI estuvo relacionado con menor Glasgow (p: 0,03), uso de inotrópicos (p: 0,01)...

Introduction: noninvasive mechanical ventilation is a technique with a fan interface - patient through a nasal or facial mask. This reduces the morbidity associated with conventional mechanical ventilation associated with endotracheal intubation and sedation of the patient relaxation. Objectives: To assess morbidity and mortality of patients undergoing non-invasive mechanical ventilation (NIMV), in the General Intensive Care Unit (GICU) of Hospital Nacional Cayetano Heredia (HNCH) from June 2007 to May 2008. Material and method: We obtained data from the GICU files from June 2007 to May 2008. We recorded physiological values when beginning and finishing NIMV and we defined success and failure when using NIMV. Results: During the one-year study, 30 patients required NIMV, their average age was 49.7 +/- 2 years, and 63.3% were women. When NIMV was started, APACHE II score was 12.7 +/- 5.6, and the SOFA score was: 4.3 +/- 2.2; 66.7% of patients presented with co-morbidities; of them, 33.3% had heart failure; 23 (76.6%) had type 1 failure respiratory, and of them, acute pulmonary edema and severe pneumonia were the most frequent causes; one patient (3.3%) had type Ii respiratory failure; 6 patients (20.1%) had both types 1 and 2 respiratory failure. We found significant differences at the end of NIMV in the following parameters: decrease of respiratory workload (p: 0.001), decreased respiratory rate (p: 0.004), decreased cardiac rate (p: 0.002), reduced systolic blood pressure (p: 0.016), reduced Fi02 requirement (p: 0.001) and increased Pa02/Fi02 rate (p: 0.001). Failure when using NIMV was related to having a lower Glasgow score (p: 0.03), with the use of inotropic substances during or after NIMV was started (p: 0.01), and a high Fi02 requirement when starting NIMV (p: 0.006)...

Glycine transporter isoforms show differential subcellular localization in PC12 cells.

The subcellular localization of glycine transporters one (GLYT1) and two (GLYT2) stably expressed in PC12 cells has been studied. To facilitate visualization, enhanced green fluorescent protein (GFP) was fused to the amino terminus of both glycine transporters. Functional analysis of the GFP-GLYT1 and GFP-GLYT2 stable cell lines demonstrated that they exhibited high affinity for glycine and the characteristic properties of both glycine transporter subtypes. The GFP-coupled transporters were differently distributed throughout the cell. GFP-GLYT1 was mainly localized on the plasma membrane, whereas most of GFP-GLYT2 was present on large dense-core vesicles and endosomes. Both transporters were absent from the synaptic vesicle population in PC12 cells.

Repelentes contra insectos / Insect repellents

Casi todos necesitamos en alguna oportunidad un repelente contra insectos, ya sea en un asado al aire libre o en un paseo por bosques o playas. Sin embargo, existe preocupación por la seguridad del empleo de dietiltoluamida (DEET) que es usado en casi todos los productos porque se han comunicado reacciones adversas y la gente tiene miedo de aplicarlos en sus niños. ¿Cuáles son efectivo e inocuos?. Los autores revisan los principales estudios en relación a los repelentes de insectos y proponen recomendaciones para un uso óptimo